Not logged in, please login to view portfolio!



GLAXO Share Price | GlaxoSmithKline Pakistan Limited

GLAXO Share Price History

GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO share price / stock price today is 106.64 PKR. Today volume traded in GLAXO is 13.9 K, price change is -2.17%, high price is 108.20 PKR, and low price is 106.50 PKR.

Company Snapshot

loading
GLAXO
2022-12-06 16:00:04
Current
106.64
Change
-2.36
Change %
-2.17%
Volume
13900
Price to Earnings Ratio
10.50
Earning per Share
10.16
Book Value
61.34
Price to Book
1.84
Market Cap
33.96 B
Dividend
7.00
Dividend Yield (%)
6.21 %
Debt to Equity
0.00
Net Profit Margin
8.05 %
Gross Profit Margin
20.57 %
Current Ratio
1.57
Face Value
10.00
Shares
318.47 M
FreeFloat
52.12 M
Free Float %
16.37
Equity to Asset(%)
53.18
Interest
7.25
Beta
0.48
Upper/Lower Cap
117.18 / 100.83
Times-Revenue Method New
52 Week High
144.70
52 Week Low
106.11
High
108.20
Low
106.50
Previous
109.00
GLAXO Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -3.318% -4.947% -8.013% -10.985% -20.79%

Company Financials
Company Announcements
Date Announce Title Attachments
2022-11-24 Notice of Corporate Briefing Session 2022 View PDF
2022-10-28 Transmission of Quarterly Report for the Period Ended September 30, 2022 View PDF
2022-10-25 Financial Results for the Quarter Ended September 30, 2022 View PDF
2022-10-18 Board Meeting View PDF
2022-09-28 Appointment of Non-Executive Director View PDF
2022-09-28 Appointment of Non-Executive Director View PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information REVOKED PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited REVISED PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information PDF
2022-08-29 Transmission of Quarterly Report for the Period Ended June 30, 2022 View PDF
2022-08-23 Financial Results for the Quarter Ended June 30, 2022 View PDF
2022-08-16 Board of Directors Meeting - August 23, 2022 View PDF
2022-08-12 Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director View PDF
2022-08-10 Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited View PDF
2022-06-30 Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 View PDF
2022-06-08 Material Information View PDF
2022-05-10 Credit of Final Cash Dividend 2021 View PDF
2022-05-06 PRIOR PUBLICAITON NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View PDF
2022-05-06 Transmission of Quarterly Report for the Period Ended March 31, 2022 View PDF
2022-04-26 Financial Results for the Quarter Ended March 31, 2022 View PDF
2022-04-25 Board Meeting In Progress View PDF
2022-04-25 Certified True Copy of Resolution - Annual General Meeting View PDF
2022-04-18 Board Meeting View PDF
2022-04-04 Notice of Annual General Meeting View PDF
2022-04-04 Transmission of Annual Report for the Year Ended 2021-12-31 View PDF
2022-03-30 Prior Publication of AGM Notice for the year 2021 View PDF
2022-02-25 Financial Results for the Year Ended December 31 2021 View PDF
2022-02-18 BOARD OF DIRECTORS MEETING View PDF
2021-12-06 Corporate Briefing Session View PDF
2021-10-29 Transmission of Quarterly Report for the Period Ended September 30, 2021 View PDF
2021-10-25 Financial Results for the Quarter Ended September 30, 2021 View PDF
2021-10-18 Board of Directors Meeting View PDF
2021-09-17 CONVERSION OF PHYSICAL SHARES INTO BOOK ENTRY FORM View PDF
2021-08-27 Transmission of Quarterly Report for the Period Ended 2021-06-30 View PDF
2021-08-23 Financial Results for the Quarter ended June 30, 2021 View PDF
2021-08-20 Board Meeting Reschedule View PDF
2021-08-16 Board of Directors Meeting View PDF
2021-06-01 Appointment of Chief Financial Officer and Executive Director View PDF
2021-05-17 CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 View PDF
2021-05-04 PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View PDF
2021-04-30 Transmission of Quarterly Report for the Period Ended 2021-03-31 View PDF
2021-04-28 Financial Results for the Quarter ended March 31, 2021 View PDF
2021-04-27 CERTIFIED TRUE COPY OF RESOLUTION View PDF
2021-04-27 MEETING IN PROGRESS View PDF
2021-04-20 Board of Directors Meeting View PDF
2021-04-06 Notice of Annual General Meeting View PDF
2021-04-06 Notice of Annual General Meeting View PDF
2021-04-06 Transmission of Annual Report for the Year Ended 2020-12-31 View PDF
2021-04-05 PRIOR PUBLICATION NOTICE OF ANNUAL GENERAL MEETING View PDF
2021-03-31 Material Information View PDF
2021-03-10 Financial Results for the Year Ended December 31, 2020 View PDF
2021-03-09 GLAXO | GlaxoSmithKline Pakistan Limited PDF
2021-03-02 Board of Directors Meeting View PDF

About Company

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

Address
35 - Dockyard Road, West Wharf,
Website
www.gsk.com.pk
Key People
Mr.Dmytro Oliinyk Chairperson
Ms. Erum Shakir Rahim CEO
Mr. Syed Azeem Abbas Naqvi Company Secretary

Page description

GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO Share Price / Stock Price is 106.64 PKR. You can also check; Share Price History, GLAXOPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

GLAXO Share Price GLAXO Stock Price GlaxoSmithKline Pakistan Limited psx stock kse100 stock GLAXO Stock Price KSE100 ALLSHR KMI30 KMIALLSHR Share price History GLAXO Payouts Annoucements Snapshot GLAXO Address GLAXO CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages GLAXO Chairperson GLAXO Secretary GLAXO Website About GLAXO

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

If you are someone who is keen on investments but does not have the time to research, identify stock market patterns, and keep track of stocks, forex, mutual funds, cryptocurrencies and other commodities like Gold and silver, then Sarmaaya is your meeting place, the crossroads where you can find everything you need to make the best decisions in the trading market. Based on unbiased, accurate and free information.

© 2022 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.